The post Ultra-rich family offices bought beaten up stocks during market rally appeared on BitcoinEthereumNews.com. Carolina Panthers owner David Tepper listens to a question during a press conference in 2022. Alex Slitz | Tribune News Service | Getty Images A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Private investment firms of the ultra-wealthy bought beaten up stocks last quarter as AI enthusiasm boosted global markets to record highs, according to third-quarter securities filings analyzed by CNBC. Hedge-fund billionaire David Tepper’s family office Appaloosa exited its entire stake in Oracle in the three months ended Sept. 30. During that period, shares of the software giant rallied by nearly 29%. Last quarter, Appaloosa locked in gains for “Magnificent Seven” stocks by closing its stake in Intel and trimming its Meta holdings by 8%. Meanwhile, Appaloosa doubled down on tariff-beaten consumer stocks, increasing its stake in Whirlpool by 2,000%. Appaloosa’s 5.5 million shares in the home appliance company ranked as its third-largest holding at the quarter-end, worth $432 million. In the second half of the year, Whirlpool stock fallen by almost 31% thus far. Tepper’s firm also upped its stake in Goodyear Tire & Rubber, which is down 13% this year. Get Inside Wealth directly to your inbox Carl Icahn’s namesake family office is also betting on a turnaround for a consumer stock, increasing its holdings of International Flavors & Fragrances by 27% to $292 million. IFF, which is down 23% for the year, produces ingredients for a wide array of consumer products from potato chips to deodorant. Icahn, a longtime activist investor, first built his IFF stake in 2022, and his son Brett joined the firm’s board in late October per a prior agreement between IFF and Icahn Capital. Omega Advisors, Leon Cooperman’s… The post Ultra-rich family offices bought beaten up stocks during market rally appeared on BitcoinEthereumNews.com. Carolina Panthers owner David Tepper listens to a question during a press conference in 2022. Alex Slitz | Tribune News Service | Getty Images A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Private investment firms of the ultra-wealthy bought beaten up stocks last quarter as AI enthusiasm boosted global markets to record highs, according to third-quarter securities filings analyzed by CNBC. Hedge-fund billionaire David Tepper’s family office Appaloosa exited its entire stake in Oracle in the three months ended Sept. 30. During that period, shares of the software giant rallied by nearly 29%. Last quarter, Appaloosa locked in gains for “Magnificent Seven” stocks by closing its stake in Intel and trimming its Meta holdings by 8%. Meanwhile, Appaloosa doubled down on tariff-beaten consumer stocks, increasing its stake in Whirlpool by 2,000%. Appaloosa’s 5.5 million shares in the home appliance company ranked as its third-largest holding at the quarter-end, worth $432 million. In the second half of the year, Whirlpool stock fallen by almost 31% thus far. Tepper’s firm also upped its stake in Goodyear Tire & Rubber, which is down 13% this year. Get Inside Wealth directly to your inbox Carl Icahn’s namesake family office is also betting on a turnaround for a consumer stock, increasing its holdings of International Flavors & Fragrances by 27% to $292 million. IFF, which is down 23% for the year, produces ingredients for a wide array of consumer products from potato chips to deodorant. Icahn, a longtime activist investor, first built his IFF stake in 2022, and his son Brett joined the firm’s board in late October per a prior agreement between IFF and Icahn Capital. Omega Advisors, Leon Cooperman’s…

Ultra-rich family offices bought beaten up stocks during market rally

Carolina Panthers owner David Tepper listens to a question during a press conference in 2022.

Alex Slitz | Tribune News Service | Getty Images

A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox.

Private investment firms of the ultra-wealthy bought beaten up stocks last quarter as AI enthusiasm boosted global markets to record highs, according to third-quarter securities filings analyzed by CNBC.

Hedge-fund billionaire David Tepper’s family office Appaloosa exited its entire stake in Oracle in the three months ended Sept. 30. During that period, shares of the software giant rallied by nearly 29%. Last quarter, Appaloosa locked in gains for “Magnificent Seven” stocks by closing its stake in Intel and trimming its Meta holdings by 8%.

Meanwhile, Appaloosa doubled down on tariff-beaten consumer stocks, increasing its stake in Whirlpool by 2,000%. Appaloosa’s 5.5 million shares in the home appliance company ranked as its third-largest holding at the quarter-end, worth $432 million. In the second half of the year, Whirlpool stock fallen by almost 31% thus far. Tepper’s firm also upped its stake in Goodyear Tire & Rubber, which is down 13% this year.

Get Inside Wealth directly to your inbox

Carl Icahn’s namesake family office is also betting on a turnaround for a consumer stock, increasing its holdings of International Flavors & Fragrances by 27% to $292 million. IFF, which is down 23% for the year, produces ingredients for a wide array of consumer products from potato chips to deodorant. Icahn, a longtime activist investor, first built his IFF stake in 2022, and his son Brett joined the firm’s board in late October per a prior agreement between IFF and Icahn Capital.

Omega Advisors, Leon Cooperman’s hedge-fund-turned-family-office, leaned into health insurance stocks, increasing its Cigna stake by 53% to 325,000 shares. Cooperman’s firm also widened its position in Elevance Health by 21%, making it Omega Advisor’s eighth-largest holding with a quarter-end value of $110.2 million. Shares of Cigna and Elevance are both down about 18% for the second half of the year, pressured by rising medical costs and anticipated government cuts to healthcare funding.

These bold bets aside, family offices are still buying the rally of some Mag 7 stocks. Soros Fund Management increased its stakes in Apple and Amazon by 2,000% and 481%, respectively. Amazon shares make up the firm’s largest holding with a quarter-end value of $489 million.

Stanley Druckenmiller’s Duquesne Family Office initiated positions in Amazon and Meta of $96 million and $56 million, respectively, after exiting them in the prior quarter.

Even Appaloosa, having whittled down its positions in several tech giants, upped its Nvidia holdings by 9%.

Source: https://www.cnbc.com/2025/11/20/billionaire-family-offices-stock-bets-market-rally.html

Market Opportunity
Ostrich Logo
Ostrich Price(RICH)
$0,00011
$0,00011$0,00011
-%8,33
USD
Ostrich (RICH) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23